Original disclosure @ AIIB website
Updated in EWS Jul 7, 2024
Contribute Information
Can you contribute information about this project?
Contact the EWS Team
According to the AIIB, the project development objective is to finance and support the growth and venture capital fund which invests in healthcare technology and digital hospital companies with a focus in China. The project aims to foster more mature applications of technology and digitalization to improve capacity, efficacy, inclusiveness and resilience of the Chinese healthcare infrastructure and service delivery.
This project will address the changing healthcare demands and more complex healthcare challenges by facilitating technology applications and digitalization of the healthcare industry in China. The Fund targets to invest in early stage and growth stage healthcare companies, covering the following primary sub-sectors: medical technology, digital health and professional services and biotechnology.
The AIIB categorized the project E&S risks as 'FI'.
As stated on the company's website, founded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, Seoul and Singapore.
It currently manages USD and RMB funds of over US$10 billion in commitments , and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add.
AIIB Team Leaders:
Stefen Shin - Principal Investment Officer, Capital Markets & Structured Products
Email: stefen.shin@aiib.org
Rusu Lee - Senior Portfolio Management Officer
Email: rusu.lee@aiib.org
Financial Intermediary - Legend Capital Co., Ltd.:
Junfeng Wang - Managing Director, Legend Capital Co., Ltd
Email: wangjf@legendcapital.com.cn
ACCESS TO INFORMATION
You can submit an information request for project information at: https://www.aiib.org/en/contact/information-request/index.html
ACCOUNTABILITY MECHANISM OF AIIB
The AIIB has established the Accountability Mechanism for Project-Affected People (PPM). The PPM provides Òan opportunity for an independent and impartial review of submissions from Project-affected people who believe they have been or are likely to be adversely affected by AIIBÕs failure to implement the ESP in situations when their concerns cannot be addressed satisfactorily through Project level GRMs or AIIB Management processes.Ó Two or more project-affected people can file a complaint. Under the current AIIB policy, when the bank co-finances a project with another development bank, it may apply the other bank's standards. You can refer to the Project Summary Information document to find out which standards apply. You can learn more about the PPM and how to file a complaint at: https://www.aiib.org/en/about-aiib/who-we-are/project-affected-peoples-mechanism/how-we-assist-you/index.html
The complaint submission form can be accessed in Arabic, Bahasa Indonesia, Bengali, Chinese, English, Tagalog, Hindi, Nepali, Russian, Turkish, or Urdu. The submission form can be found at: https://www.aiib.org/en/about-aiib/who-we-are/project-affected-peoples-mechanism/submission/index.html